Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan versus losartan crossover study in renal transplant recipients
2008-000822-38Phase 2Completed
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of telmisartan and losartan in hypertension (HTN) (2 arms), sponsored by Mario Negri Institute for Pharmacological Research. Primary endpoint: Insulin sensitivity. Started Mar 2009; status: completed.
02
Drugs
telmisartanlosartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2008-000822-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000822-38.